Home › Funds › DAGCO, INC. › SLS

DAGCO, INC. position in SLS

SELLAS LIFE SCIENCES GROUP I · Health Care

DAGCO, INC. reported holding 1,336,449 shares of SLS (SELLAS LIFE SCIENCES GROUP I) in its Q3 2026 13F filing — a position valued at US$16.5M, representing 2.85% of its reported portfolio and ranking #11 among its reported holdings. DAGCO, INC. has disclosed SLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.34M sh
Reported value held$16.45M
Portfolio Weight2.85%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DAGCO, INC.'s SLS position evolved

DAGCO, INC. first disclosed a stake in SLS in Q4 2025 at 577,540 shares (US$2.2M). The position peaked in Q2 2026 at 1,232,433 shares, worth US$18.2M. Across 4 filings, DAGCO, INC. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,336,449 shares valued at US$16.5M — an increase of 104,016 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2026 (shares rose 249% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 577.54K $2.18M New
Q1 2026 1.03M $4.35M Add
Q2 2026 1.23M $18.19M Add
Q3 2026 1.34M $16.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLS and 13F data

SLS (SELLAS LIFE SCIENCES GROUP I) is a Health Care company. 106 other funds we track also report a position in SLS — the largest reported positions include Sio Capital Management, LLC (US$18.2M), Anson Funds Management LP (US$11.8M), Ikarian Capital, LLC (US$5.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLS

All SLS fund holders →

FAQ

How long has DAGCO, INC. held SLS?

DAGCO, INC. has disclosed SLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is DAGCO, INC.'s current position in SLS?

As of Q3 2026, DAGCO, INC. holds 1.34M shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $16.45M, representing 2.85% of its reported portfolio and ranking #11.

Has DAGCO, INC. been buying or selling SLS?

In the latest 13F filing (Q3 2026), DAGCO, INC. increased its position in SLS. The position peaked in Q2 2026 at 1.23M shares.

Which other funds hold SLS?

Other major institutional holders of SLS include Sio Capital Management, LLC, Anson Funds Management LP, Ikarian Capital, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.